Filter by: patients
Home > Community Treatment Reports and Side Effects > Zalcitabine (ddC) Treatment Report
What is Zalcitabine (ddC)?

Zalcitabine, also known as ddC, is used alone or with other anti-retroviral medications to treat human immunodeficiency virus (HIV) infection in patients with acquired immunodeficiency syndrome (AIDS).

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 3 0
Other 1 0
Improve communication 1 0
Increase effect of another treatment 1 0

See 1 patient currently taking Zalcitabine (ddC)

Mouse over the table for more information

Reported Dosages

  20 mg daily
  1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Zalcitabine (ddC) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 40%
Did not seem to work 1   Did not seem to work: 20%
Side effects too severe 1   Side effects too severe: 20%
Other 1   Other: 20%

See all 5 patients who’ve stopped taking Zalcitabine (ddC)

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Zalcitabine (ddC)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Report created on May 28, 2012.